DOW JONES21,636.78-915.39 -4.06%
S&P 5002,541.47-88.60 -3.37%
NASDAQ7,502.38-295.16 -3.79%

HC Wainwright & Co. Maintains Buy on AVEO Pharmaceuticals, Raises Price Target to $4

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains AVEO Pharmaceuticals (NASDAQ:AVEO) with a Buy and raises the price target from $1.75 to $4.

Benzinga · 03/18/2020 11:15

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains AVEO Pharmaceuticals (NASDAQ:AVEO) with a Buy and raises the price target from $1.75 to $4.